antipyrine has been researched along with Fascioliasis in 7 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
Fascioliasis: Liver disease caused by infections with parasitic flukes of the genus FASCIOLA, such as FASCIOLA HEPATICA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The half-life of sulphadimidine was also significantly prolonged 5, 9 and 16 weeks after infection." | 5.30 | The effect of experimental fascioliasis on the pharmacokinetics of antipyrine and sulphadimidine in desert sheep. ( Ali, BH; Elsheikh, HA, 1997) |
| " The plasma elimination half-life of antipyrine was significantly elevated by 23% at 11 weeks postinfection (p." | 1.31 | Effect of experimental fasciolosis on antipyrine metabolism and clearance in water buffaloes. ( Bayón, JE; Ferre, I; González-Gallego, J; Jiang, SX; Mao, XZ, 2000) |
| " The half-life of sulphadimidine was also significantly prolonged 5, 9 and 16 weeks after infection." | 1.30 | The effect of experimental fascioliasis on the pharmacokinetics of antipyrine and sulphadimidine in desert sheep. ( Ali, BH; Elsheikh, HA, 1997) |
| "Antipyrine clearance was used to assess microsomal oxidative function in eight female Churra breed sheep at 20, 30, 40, 60, 80 and 100 days after infection by an oral administration of 150 metacercariae of Fasciola hepatica." | 1.29 | Experimental ovine fasciolosis: antipyrine clearance as indicator of liver damage. ( Ferre, I; González-Gallego, J; López, P; Rojo-Vázquez, FA, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benchaoui, HA | 1 |
| McKellar, QA | 1 |
| Ferre, I | 2 |
| López, P | 1 |
| Rojo-Vázquez, FA | 1 |
| González-Gallego, J | 2 |
| Elsheikh, HA | 1 |
| Ali, BH | 2 |
| Jiang, SX | 1 |
| Bayón, JE | 1 |
| Mao, XZ | 1 |
| el Sheikh, HA | 1 |
| Burrows, GE | 1 |
| Tasler, J | 1 |
| Boray, JC | 1 |
| Egerton, J | 1 |
| Tufenkji, AE | 1 |
| Alvinerie, M | 1 |
| Pineau, T | 1 |
| Boulard, C | 1 |
| Galtier, P | 1 |
1 review available for antipyrine and Fascioliasis
| Article | Year |
|---|---|
Some comparative aspects of drug metabolism in nubian goats (Capra hircus), desert sheep (Ovis aries) and dromedary camels (Camelus dromedarius).
Topics: Animals; Antipyrine; Camelus; Fascioliasis; Goats; Liver; Pharmaceutical Preparations; Sheep; Sulfam | 1992 |
6 other studies available for antipyrine and Fascioliasis
| Article | Year |
|---|---|
Effect of early treatment with rafoxanide on antipyrine clearance in sheep infected with Fasciola hepatica.
Topics: Animals; Antipyrine; Fasciola hepatica; Fascioliasis; gamma-Glutamyltransferase; Glutamate Dehydroge | 1993 |
Experimental ovine fasciolosis: antipyrine clearance as indicator of liver damage.
Topics: Animals; Antipyrine; Biomarkers; Fasciola hepatica; Fascioliasis; Female; gamma-Glutamyltransferase; | 1996 |
The effect of experimental fascioliasis on the pharmacokinetics of antipyrine and sulphadimidine in desert sheep.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Area Under Curve; Fascioliasis; Half-L | 1997 |
Effect of experimental fasciolosis on antipyrine metabolism and clearance in water buffaloes.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Helminth; Antipyrine; Aspartate Aminot | 2000 |
Antipyrine, erythromycin and oxytetracycline disposition in experimental fasciolosis.
Topics: Animals; Antipyrine; Cattle; Cattle Diseases; Erythromycin; Fascioliasis; Female; Male; Oxytetracycl | 1992 |
Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
Topics: Animals; Antipyrine; Cytochrome P-450 Enzyme System; Fascioliasis; Liver; Male; Metabolic Clearance | 1988 |